GGrantIndex
← Leaderboards

Sam Mesiano

Case Western Reserve University

$7,893,511
Attributed
$9,431,501
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY200625
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,431,501 · 7

By mechanism

R01$8,847,491 · 5
R21$431,750 · 1
R03$152,260 · 1

Top collaborators

Most similar at Case Western Reserve University

Same institution · by research overlap

Others in their field

Top investigators on “Progesterone

Research focus

ProgesteroneReceptorPremature BirthAffectPreventMediatingCellsWithdrawalNeonatal MortalityPregnancyMyometriumBirthNeonatal MorbidityTissuesNuclearSteroid HormoneUterusInflammatoryStimulusResponseInflammationProgesterone ReceptorsAnti-Inflammatory AgentsPremature Labor

Grant awards (24)

Drug repurposing of a novel synthetic progestin for the prevention of preterm labor and fetal inflammation$666,882
R01 · FY2025 · HD
Paracrine control of the maternal-fetal interface critical for pregnancy wellness$560,036
R01 · FY2025 · HD
A novel mechanism for inflammation-induced preterm birth via PR-A phosphorylation$483,697
R01 · FY2025 · HD · contact PI
Drug repurposing of a novel synthetic progestin for the prevention of preterm labor and fetal inflammation$696,840
R01 · FY2024 · HD
Paracrine control of the maternal-fetal interface critical for pregnancy wellness$554,436
R01 · FY2024 · HD
A novel mechanism for inflammation-induced preterm birth via PR-A phosphorylation$478,860
R01 · FY2024 · HD · contact PI
Paracrine control of the maternal-fetal interface critical for pregnancy wellness$597,786
R01 · FY2023 · HD
A novel mechanism for inflammation-induced preterm birth via PR-A phosphorylation$483,697
R01 · FY2023 · HD · contact PI
Development of therapeutics to prevent spontaneous preterm birth$335,282
R01 · FY2023 · HD · contact PI
A novel mechanism for inflammation-induced preterm birth via PR-A phosphorylation$488,253
R01 · FY2022 · HD · contact PI
Development of therapeutics to prevent spontaneous preterm birth$335,282
R01 · FY2022 · HD · contact PI
A novel mechanism for inflammation-induced preterm birth via PR-A phosphorylation$558,891
R01 · FY2021 · HD · contact PI
Development of therapeutics to prevent spontaneous preterm birth$335,282
R01 · FY2021 · HD · contact PI
Development of therapeutics to prevent spontaneous preterm birth$340,531
R01 · FY2020 · HD · contact PI
Development of therapeutics to prevent spontaneous preterm birth$340,000
R01 · FY2019 · HD · contact PI
Role of nuclear progesterone receptors in the control of human parturition$322,517
R01 · FY2016 · HD · contact PI
Role of nuclear progesterone receptors in the control of human parturition$317,630
R01 · FY2015 · HD · contact PI
Role of nuclear progesterone receptors in the control of human parturition$316,653
R01 · FY2014 · HD · contact PI
Role of nuclear progesterone receptors in the control of human parturition$309,161
R01 · FY2013 · HD · contact PI
Role of nuclear progesterone receptors in the control of human parturition$325,775
R01 · FY2012 · HD · contact PI
Genomic actions of progesterone receptors in human myometrial cells$196,250
R21 · FY2010 · HD · contact PI
Genomic actions of progesterone receptors in human myometrial cells$235,500
R21 · FY2009 · HD · contact PI
Myometrial PRs/ERs:targets for the prevention of preterm labor$75,010
R03 · FY2007 · HD · contact PI
Myometrial PRs/ERs:targets for the prevention of preterm labor$77,250
R03 · FY2006 · HD · contact PI